LDHA and Parkinson disease: The metabolism of dopamine results in the formation of toxic 3,4-dihydroxyphenylacetaldehyde (DOPAL) and H2O2, which are found in elevated concentrations in PD patients due to decreased vesicular uptake of cytosolic dopamine and decreased DOPAL detoxification by ALDH.